Cite Score:
0.73
ELSEVIER SCOPUS

Concurrent Presence of Cryptococcal Meningitis and Neoplastic Meningitis in a Recipient of Hematopoietic Stem Cell Transplantation: A Case Report

AUTHORS

Kouros Aghazadeh 1 , * , Seyed Alireza Nadji 2 , Shervin Shokouhi 3 , Payam Tabarsi 4 , Raziyeh Niyati 1

AUTHORS INFORMATION

1 Infectious Diseases and Tropical Medicine Research Center, Shahid Behshti University of Medical Sciences, Tehran, IR Iran

2 Associate Professor of Medical Virology, VRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

3 Department of Infectious Disease, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

4 Clinical TB and Epidemiology Research Center, NRITLD, Tehran, IR Iran

How to Cite: Aghazadeh K, Nadji S A, Shokouhi S, Tabarsi P, Niyati R. Concurrent Presence of Cryptococcal Meningitis and Neoplastic Meningitis in a Recipient of Hematopoietic Stem Cell Transplantation: A Case Report, Arch Clin Infect Dis. 2016 ; 11(2):e31067. doi: 10.5812/archcid.31067.

ARTICLE INFORMATION

Archives of Clinical Infectious Diseases: 11 (2); e31067
Published Online: March 19, 2016
Article Type: Case Report
Received: June 26, 2015
Revised: January 26, 2016
Accepted: February 28, 2016
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Introduction: Cryptococcal meningitis is a rare disorder that is caused by Cryptococcus neoformans in immunocompromised host.

Case Presentation: The case was a 64-year-old man with a history of stem cell transplant for acute leukemia, who presented chronic meningitis caused by Cryptococcus neoformans and concurrent neoplastic meningitis with presence of malignant cells only in his cerebrospinal fluid (CSF).

Conclusions: Chronic meningitis in immunocompromised hosts can be due to more than one pathologic etiology and we should do all diagnostic evaluation to rule out all possible differential diagnosis.

Keywords

Cryptococcal Meningitis Neoplastic Meningitis Meningeal Co-Infection Hematopoietic Stem Cell Transplant

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Introduction

Although cryptococcosis is most often associated with HIV infection, in many centers, especially in more developed countries, the majority of cases occur among non-HIV-infected individuals including transplant recipients and patients, who are receiving immunosuppressive agents (1).

Little information is available regarding central nervous system (CNS) relapse of adult leukemia after allogeneic hematopoietic stem cell transplantation (HSCT) (2).

We presented an extremely rare case of CNS relapse of leukemia five years after HSCT and concurrent cryptococcal meningitis.

2. Case Presentation

A 64-year-old retired man was admitted to the emergency department of Bahman hospital in Tehran, Iran. He complained of transient loss of consciousness. He did not recall the amount of time he was unconscious. He also had a moderately severe, bi-frontal headache and limb paresthesia for the last four months. The most important point in his past medical history was a history of Acute Myeloid Leukemia (AML) (M3) and allogenic stem cell transplant five years ago. He also had a history of GVHD six months after the transplant. He had cyclosporine and prednisone as his prescribed medication.

He had travelled to the USA last year and stayed there for one month. Physical examinations were unremarkable. The results of brain magnetic resonance imaging (MRI) and electroencephalogram (EEG) were normal.

Laboratory evaluations showed a serum white blood count (WBC) of 7000 cell/mm3 with 58% neutrophil, 24% lymphocyte, 9% monocyte, and 1.7% eosinophil. Peripheral blood smear was normal. Human immunodeficiency virus (HIV) test was negative. Cerebrospinal fluid specimen was colorless, with a normal opening pressure and 4200 cell/mm3 (90% lymphocyte), glucose 40 mg/dL (with BS: 130) and protein 102 mg/dL. There was no microorganism on Gram stain. India ink preparation showed nothing.

Since the suspicion was infectious meningitis and the patients clinical condition was severe, his treatment was started with broad spectrum antibiotics (vancomycin and meropenem), antiviral (acyclovir) and antituberculosis drugs (isoniazid, rifampin, ethambutol, pyrazinamide) and vitamin B6 were started while waiting for the cytology and cultures of the CSF. We also evaluated his CSF for all the causes of chronic meningitis (the results are shown in Table 1).

Table 1. Evaluation of Cerebrospinal Results for Chronic Meningitis
TestResult
AFB stainNegative
Culture for mycobacteriaNegative
Mycobacterium tuberculosis PCRNegative
ADANormal
Gram stainingNegative
VDRLNegative
CMV PCRNegative
Cryptococci PCRPositive
Cryptococcal AntigenWeekly positive
India inkNegative
Culture for fugusNegative
CMV PCRNegative
Adenovirus PCRNegative
EBV PCRNegative
WrightNegative
CytologyMalignant cells were seen
Flow cytometryleukemic blast: about 90%, with granules and Aure rods
ACE levelNormal

Two days later, polymerase chain reaction (PCR) testing of CSF was negative for TB, but PCR for Cryptococcus was positive and serum cryptococcal antigen was positive as well. Cytology test and flow cytometry of CSF revealed presence of malignant cells (leukemic blast: about 90% with granules and Aure rods) in the CSF, establishing the diagnosis of cryptococcal meningitis and concurrent CNS infiltration. Bone marrow aspiration confirmed AML relapse.

Instead of antibiotics (antiviral and anti-tuberclosis agents) the patient started receiving Amphotericin B, and was scheduled for chemotherapy.

Two weeks after starting antifungal therapy, he felt well and was referred for chemotherapy. Unfortunately four weeks after he received intrathecal chemotherapy his clinical condition was complicated with hospital acquired pneumonia and finally he died from respiratory failure.

3. Discussion

Central nervous system (CNS) infiltration in Acute Myeloid Leukemia (AML) is a rare event with an estimated incidence below 5% at diagnosis. In one study the overall frequency of neoplastic meningitis (NM) throughout the whole treatment period including primary diagnosis, all cytoreductive chemotherapy cycles and also post-transplant course was as high as 15% (3).

Clinical presentation of CNS involvement in AML may be indolent. However, patients with symptoms of increased intracranial pressure such as mental changes and headache, cranial nerve palsies, CNS hemorrhage, symptoms of spinal cord compression, and visual changes should be checked for CNS infiltration with lumbar puncture and radiology imaging studies. Most patients exhibit moderate elevation in protein and moderate decrease in glucose, which was true for our patient’s CSF. Computerized tomography (CT) and MRI, can exclude hemorrhage, stroke, and brain tumor. In addition, in case of cranial nerve palsies and negative CSF, MRI can prove very helpful in recognizing signs of CNS infiltration (4). In our case, neither brain MRI nor brain CT scan was indicative of CNS infiltration.

Cryptococcus is an opportunistic fungus that is an important cause of CNS infections among immunocompromised patients, but it has only rarely been reported in non-HIV-positive patients. The most common forms of immunosuppression (other than HIV) include chronic glucocorticoid use, history of organ transplantation, malignancy, as well as sarcoidosis and liver failure (5).

A study has shown that patients with an immunosuppressed condition, especially T-cell suppression, may present less typical clinical manifestations of meningitis (6). The clinical manifestations of cryptococcal meningitis depend largely on the host immune status. Nausea, vomiting, and altered mental status occur in about half of the patients. Signs and symptoms of meningismus affect less than 25% of patients. Visual symptoms, such as diplopia and blindness, occur in about 20% of patients, most often in immunocompetent patients. Seizures and focal neurologic deficits occur in 10% of patients and are generally caused by space-occupying lesions such as cryptococcomas or granulomas (7).

Our purpose to introduce this patient was remembering the important point that in immunocompromised hosts, especially patients, who manifest with neurologic symptoms, diagnostic evaluations should be done completely and all differential diagnosis should be ruled out because of the possibility of more than one pathologic process as an etiologic agent and empiric treatment with antibiotics, antivirals, antifungals, and steroids should be implemented on a case-by-case basis. Also tuberculosis is the leading cause of chronic meningitis in our country, thus we should be aware of its other causes, and even co-infections. Moreover, cryptococcal infections have been infrequently reported from Iran, but all the factors for its existence are available in this part of the world (8) and central nervous system co-infection with tuberculosis and Cryptococcus neoformans has also been reported (9).

Acknowledgements

References

  • 1. Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc. 2013; 124 : 61 -79 [PubMed]
  • 2. Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008; 14(10) : 1100 -7 [DOI][PubMed]
  • 3. Bommer M, von Harsdorf S, Döhner H, Bunjes D, Ringhoffer M. Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation. haematologica. 2010; 95(11) : 1969 -72
  • 4. Vasilatou D, Papageorgiou S, Bazani E, Prasouli A, Economopoulou C, Roumpakis C, et al. CNS Involvement in AML Patient Treated with 5-Azacytidine. Case reports in hematology. 2014; 2014
  • 5. Kushawaha A, Mobarakai N, Parikh N, Beylinson A. Cryptococcus neoformans meningitis in a diabetic patient-the perils of an overzealous immune response: a case report. Cases J. 2009; 2 : 209
  • 6. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM. 2000; 93(4) : 245 -51 [PubMed]
  • 7. Baldwin KJ, Zunt JR. Evaluation and treatment of chronic meningitis. Neurohospitalist. 2014; 4(4) : 185 -95 [DOI][PubMed]
  • 8. Badali H, Alian S, Fakhim H, Falahatinejad M, Moradi A, Mohammad Davoudi M, et al. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Mycoses. 2015; 58(12) : 689 -93 [DOI][PubMed]
  • 9. Razin BN, Shoaei SD, Family A, Nabavi M, Abbasi F. Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman. Archives of Clinical Infectious Diseases. 2011; 6(2) : 93 -4
  • COMMENTS

    LEAVE A COMMENT HERE: